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Abstract The paired box transcription factor Pax8 is
critical for development of the eye, thyroid gland as well as
the urinary and reproductive organs. In adult, Pax8 over-
expression is associated with kidney, ovarian and thyroid
tumors and has emerged as a specific marker for these
cancers. Recently, Pax8 expression was also reported in
human pancreatic islets and in neuroendocrine tumors,
identifying Pax8 as a novel member of the Pax family
expressed in the pancreas. Herein, we sought to provide a
comprehensive analysis of Pax8 expression during pan-
creogenesis and in adult islets. Immunohistochemical
analysis using the most employed Pax8 polyclonal anti-
body revealed strong nuclear staining in the developing
mouse pancreas and in mature human and mouse islets.
Astonishingly, Pax8 mRNA in mouse islets was undetect-
able while human islets exhibited low levels. These
discrepancies raised the possibility of antibody cross-
reactivity. This premise was confirmed by demonstrating
that the polyclonal Pax8 antibody also recognized the islet-
enriched Pax6 protein both by Western blotting and
immunohistochemistry. Thus, in islets polyclonal Pax8
staining corresponds mainly to Pax6. In order to circum-
vent this caveat, a novel Pax8 monoclonal antibody was
used to re-evaluate whether Pax8 was indeed expressed in
islets. Surprisingly, Pax8 was not detected in neither the
developing pancreas or in mature islets. Reappraisal of
pancreatic neuroendocrine tumors using this Pax8 mono-
clonal antibody exhibited no immunostaining as compared
to the Pax8 polyclonal antibody. In conclusion, Pax8 is not
expressed in the pancreas and cast doubts on the value of
Pax8 as a pancreatic neuroendocrine tumor marker.
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Introduction
A complex network of transcription factors controls pan-
creatic islet development as well as its subsequent mature
function responsible for the exquisite maintenance of blood
glucose homeostasis (Servitja and Ferrer 2004). Of par-
ticular interest is the family of paired box (Pax) genes,
which encode key regulators of tissue development and
cellular differentiation. The Pax transcription family com-
prises 9 members divided into 4 groups based on the
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specific assembly of 3 structural domains; the highly con-
served 128 amino acid DNA binding paired domain, the
octapeptide and a complete or residual DNA interacting
homeodomain. Combinations of individual Pax members
are spatially as well as temporally regulated during
development and contribute to the formation of diverse
organs (Lang et al. 2007).
Two members of this family, Pax6 and Pax4, compris-
ing group IV and typified by the lack of the octapeptide
domain, were shown to be essential for pancreatic islet
organogenesis and function. Indeed, deletion of Pax4 in
mice results in the absence of both b- and d-cells with a
concomitant increase in a-cells (Sosa-Pineda 2004). In
contrast, deletion of Pax6 results in the absence of a-cells
together with a decrease in the other types of pancreatic
endocrine cells (St-Onge et al. 1997). Although b-, d- and
PP-cells are still present, they fail to form distinct islets and
remain disorganize throughout the exocrine pancreas,
suggesting that Pax6 is not only essential for a-cell dif-
ferentiation but also for cell migration necessary for islet
formation (St-Onge et al. 1997). Animals with both Pax6
and Pax4 ablation completely lack pancreatic islets dem-
onstrating the absolute requirement of both Pax factors for
islet generation.
Surprisingly Pax8, which is essential for development of
the eye, thyroid gland as well as the urinary and repro-
ductive organs, has recently emerged as a new member of
the Pax family involved in islet physiology. Indeed,
although previous reports have not detected Pax8 expres-
sion in pancreatic islets (Goode and Elgar 2009), more
recent studies claim strong Pax8 immunostaining in pan-
creatic neuroendocrine tumors (Haynes et al. 2011; Long
et al. 2010; Sangoi et al. 2011) as well as in normal human
islets. Reported Pax8 expression in human pancreas is
restricted to the endocrine compartment, as exocrine acinar
and ductal cells exhibited no staining (Ozcan et al. 2011;
Sangoi et al. 2011). Moreover, transcript expression pro-
filing performed on islets isolated from pregnant mice
revealed a robust induction of Pax8 expression levels
during gestation (Rieck et al. 2009). In addition, a genome-
wide linkage and admixture mapping study has linked Pax8
to Type 2 diabetes in African American families (Elbein
et al. 2009). Taken together, these studies prompt us to
investigate whether Pax8 could also be expressed during
pancreatic islet development pinpointing to a potential new
role of this transcription factor in islet physiology. To
address this question, we analyzed Pax8 expression during
development using a polyclonal Pax8 antibody previously
utilized in several clinical studies that clearly demonstrated
Pax8 staining in pancreatic neuroendocrine tumors (Haynes
et al. 2011; Long et al. 2010; Sangoi et al. 2011). Con-
sistent with these studies, strong Pax8 immunostaining was
detected in the developing pancreas as well as in adult
mouse and human islets of different ages. In contrast, Pax8
mRNA levels in both human and mouse islets were low to
undetectable. In an attempt to confirm and validate the
specificity of this Pax8 antibody, we found that it cross-
reacted with the more abundant islet enriched Pax6 protein.
In order to circumvent this caveat, we used a monoclonal
antibody against Pax8 and re-evaluated whether Pax8 was
indeed detected in islets. Astonishingly, we were unable to
confirm expression of this Pax member neither in the
developing pancreas, islets nor in pancreatic neuroendo-
crine tumors. Therefore, our results cast serious doubts on
the value of Pax8 as a pancreatic neuroendocrine tumor
marker and call for vigilance in the use of non-validated
antibodies for clinical studies.
Materials and methods
Islet isolation and, culture
Pancreatic mouse islets were isolated by collagenase
(Sigma-Aldrich Quimica S.A., Madrid, ES) digestion,
handpicked and maintained in 11.1 mM glucose/RPMI-
1640 (Invitrogen S.A., Barcelona, ES) supplemented with
10% fetal calf serum (Sigma-Aldrich Quimica S.A.), 100
Units/ml penicillin and 100 mg/ml streptomycin (Sigma-
Aldrich Quimica S.A.), and 2 mM glutamine (GlutaMAX;
Invitrogen S.A.). Isolated human islets obtained from the
Cell Isolation and Transplantation Center, Geneva Uni-
versity Hospitals, were maintained in CMRL 1066 medium
w/o phenol red (Sigma-Aldrich Quimica S.A.) supple-
mented with 10% fetal calf serum (Sigma-Aldrich Quimica
S.A.), 100 Units/ml penicillin and 100 mg/ml streptomycin
(Sigma-Aldrich Quimica S.A.), 100 mg/ml gentamycin
(Sigma-Aldrich Quimica S.A.) and 2 mM glutamine
(GlutaMAX, Invitrogen S.A.).
Tissue samples and preparation
Embryonic, pup and adult mouse tissues were dissected
and fixed in 4% paraformaldehyde overnight at 4C,
embedded in paraffin and sectioned at 7 lm. Sections from
biopsies of human pancreatic neuroendocrine tumor were
kindly provided by the Hospital Universitario Virgen del
Rocio (Sevilla, Spain). Sections included both neuroendo-
crine tumor and neighbouring non-neoplastic areas.
Quantitative real time PCR (Q-RT-PCR)
Total RNA from islets was extracted using the RNeasy
Micro Kit (Qiagen, Madrid, ES) and Q-RT-PCRs per-
formed as described previously (Hu He et al. 2011).
Briefly, 2 lg RNA were used to synthesize first-strand
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cDNA using Superscript II (Invitrogen S.A.) in a total
volume of 20 lL. 3 lL of diluted cDNA samples were
used as template for the Q-RT-PCR using SYBR green
(Roche Farma S.A., Madrid, ES). Q-RT-PCR data were
normalized using the 2–DCt method for transcripts levels
evaluated in different tissues. In situation in which tran-
script levels were derived from the same tissue, the 2DDCt
method was employed and normalized to Pax6 expression
levels. Briefly, the DDCt is calculated as the Pax6 DCt
minus the DCt of the gene of interest. The DCt is calculated
as the crossing point of the housekeeping gene (cyclophi-
lin) minus the crossing point of the gene of interest. Primer
sequences listed in Table 1 were designed using the Pri-
mer3 Software (http://frodo.wi.mit.edu/primer3/).
Transient transfection and immunoblot analysis
Transient transfection of human Pax4 (Brun et al. 2008),
Pax6 and Pax8 (Origene Technologies, Rockville USA)
expressing plasmids were performed using Lipofectamine
2000 (Invitrogen S.A.) following the manufacturer’s pro-
tocol. Briefly, MCF-7 cells plated on six multiwell plates
were transfected with 4 lg DNA. 24 h after transfection
cells were harvested and whole-cell extracts were prepared
by lysing the cells at 4C for 1 h in WCB (20 mM Hepes
(pH 7.7), 300 mM NaCl, 0.2 mM EDTA, 0.1% Triton
X-100, 1.5 mM MgCl2, 0.5 mM DTT) supplemented with
protease inhibitors. 15 lg of protein extracts were resolved
in SDS-PAGE gels and transferred to PVDF membranes.
Membranes were blocked with 5% milk in Tris-buffered
saline—0.1% Tween (TBST) and subsequently incubated
overnight at 4C with the primary antibody in TBST con-
taining 3% BSA. The membranes were then incubated with
the corresponding secondary antibody in TBST-3% nonfat
milk for 1 h at room temperature and the immunoreactive
bands were visualized using the enhanced chemilumines-
cence detection system (ECL) (GE-Healthcare, Barcelona
ES). Specific antibodies were used as follow: Polyclonal
Pax8 (No 10336-1-AP ProteinTech Group, Chicago, USA)
1:500 dilution; monoclonal Pax8 (No ab53490, Abcam,
Cambridge UK) 1:100 dilution; monoclonal Pax6 (DSHB-
University of Iowa, USA) 1:1,000 dilution; c-Myc (Sigma-
Aldrich Quimica S.A.) 1 lg/mL; a-tubulin (Sigma-Aldrich
Quimica S.A.) 1:5,000 dilution.
Immunostaining
Immunohistochemistry analysis was performed as previ-
ously described (Rojas et al. 2009). Briefly, subsequent to
antigen retrieval by autoclaving in citrate buffer for mouse
tissues or in EDTA buffer using PT-Link (DAKO, Barce-
lona, ES) for human sections; tissue samples were blocked
in PBS-3% BSA for 1 h. Overnight incubation with pri-
mary antibodies (rabbit polyclonal Pax8 antibody at 1:400
dilution, mouse monoclonal Pax8 at 1:10 dilution and
monoclonal Pax6 antibody at 1:800 dilution) was per-
formed at 4C. Corresponding biotinylated secondary
antibodies (dilution 1:300) were used for 1 h at room
temperature and DAB (Vector Lab, Barcelona, ES) was
used for signal development. Counterstaining with Hema-
toxilin (Panreac, Barcelona, ES) was performed.
Alternatively, for immunofluorescence, cells grown on
coverslips were fixed 10 min at room temperature in 4%
paraformaldehyde and methanol for 2 min at -20C. Cells
were then permeabilized with PBS containing 0.1% Tween-
20 and 2% BSA and blocked in 5% BSA in TBS-0.1% Triton
X-100. Primary antibodies, rabbit polyclonal Pax8 antibody
at 1:800 dilution, a mouse monoclonal Pax8 at 1:10 dilution
and a monoclonal Pax6 antibody at 1:800 dilution, were used
overnight at 4C. Secondary antibodies used were either
rabbit or mouse Alexa Fluor 568 and Alexa Fluor 488.
Counterstaining with DAPI was performed in order to reveal
nuclei. The slides were analyzed using epifluorescence
microscopy (Leica DM6000B, Leica).
Results
Pax8 transcript levels are low to undetectable
in adult pancreatic islets
Recent studies revealing Pax8 staining in human pancreatic
neuroendocrine tumors as well as in normal adult islets
Table1 Sequence of the primers used in the study
Gene Primers (50–30)
Human
Pax4 Forw. ACCCCACCTAAAGCCTGTCT
Rev. AGGCAAAGCAGTCCTGAGTC
Pax6 Forw. CTCGGGCACCACTTCAACA
Rev. TCCGGGAACTTGAACTGGAA
Pax8 Forw. CCCCCTACTCCTCCTACAGC
Rev. GGCCTTGATGTGGAACTGTAA
Cyclophilin Forw. TACGGGTCCTGGCATCTTGT
Rev. CCATTTGTGTTGGGTCCAGC
Mouse
Pax4 Forw. TCGAATTGCCCAGCTAAAGG
Rev. TTCAGTGCAAAGCTGGTGTTG
Pax6 Forw. CAACCTGGCTAGCGAAAAGC
Rev. TCTGCCCGTTCAACATCCTT
Pax8 Forw. GTTTGAGCGGCAGCATTAC
Rev. GTAAGGGCAGTGGGTACAGC
Cyclophilin Forw. ATGGCAAATGCTGGACCAA
Rev. GCCATCCAGCCATTCAGTCT
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prompted us to evaluate expression levels of this tran-
scription factor in human and mouse islets as compared to
Pax6 and Pax4, two Pax family members expressed in the
endocrine pancreas. Consistent with previous reports (Brun
et al. 2004; Hu He et al. 2011; Kutlu et al. 2009), Pax6 was
highly expressed in both human and mouse islets whereas
Pax4 levels were much lower, nonetheless detectable
(Fig. 1). In contrast, the Pax8 transcript was not detected in
mouse islets whereas human islets exhibited low levels as
compared to Pax6 and Pax4 (Fig. 1). As several Pax8
splice variants have been reported (Kozmik et al. 1993),
various combinations of primers were evaluated to elimi-
nate the possibility that only a subset of these spliced
transcripts were expressed in islets. Astonishingly, identi-
cal results were obtained independently of the primer pairs
used (Data not shown).
A Pax8 polyclonal antibody reveals staining
in the developing mouse pancreas and in neonatal islets
Low levels of the Pax8 transcript in adult islets led us to
investigate whether Pax8 expression could be temporally
expressed during development. To address this question,
we performed immunohistochemical analysis on kidney,
pancreas and liver of mouse embryos at embryonic stage
(E)15.5 and E17.5 as well as newborn pups using the most
cited Pax8 polyclonal antibody. We opted for this approach
in order to accurately determine whether Pax8 is specifi-
cally expressed in the developing pancreas. Consistent with
a previous study detecting Pax8 transcript (Plachov et al.
1990), strong Pax8 nuclear immunostaining was observed
in the endodermal compartment of both the developing and
newborn kidney (Fig. 2A; a, d and g). In the liver, Pax8
staining was only detected in scattered cells (Fig. 2A; c, f
and i). Consistent with our hypothesis, the developing
pancreas also exhibited Pax8 staining in the endocrine
compartment while the surrounding exocrine tissue dis-
played no expression of the transcription factor (Fig. 2A; b
and e). Intriguingly, Pax8 immunostaining also persisted in
the majority of islets cells of neonatal animals (Fig. 2A; h).
These findings were substantiated by immunofluorescence
analysis (Fig. 2B).
The Pax8 polyclonal antibody reveals immunostaining
in the adult pancreas
Detection of Pax8 positive cells in neonatal islets using a
polyclonal antibody prompt us to investigate whether the
protein could also be detected in adult islets. Consistent
with the immunostaining observed in embryos and new-
born mice, Pax8 was also detected in most cells of adult
mouse and human islets (Fig. 3A). Surprisingly, these
results are in sharp contrast to our gene expression analysis
in which the Pax8 transcript was not detected in adult
mouse islets (Fig. 1). In order to verify these results,
immunohistochemistry analysis were repeated using a
recently commercialized Pax8 monoclonal antibody gen-
erated against the C-terminal region of Pax8. In contrast to
the polyclonal antibody, the monoclonal Pax8 antibody
revealed no staining in either islets from adult mice or
human (Fig. 3B). Discrepancies in the immunohistochem-
ical data combined with undetectable Pax8 transcripts in
islets raise the possibility that the Pax8 polyclonal antibody
may cross-react with other pancreatic islet-enriched Pax
members.
The polyclonal Pax8 antibody cross-reacts
with the islet-enriched Pax6 family member
To authenticate or rebut the specificity of the Pax8 poly-
clonal antibody, we performed Western blotting analysis
on cells transfected with either Pax6 or Pax4 expressing
vectors. These two Pax members are expressed in both the
developing pancreas as well as in mature islets (Brun et al.
2004, 2008; Sosa-Pineda et al. 1997; St-Onge et al. 1997)
(Fig. 1). In order to identify the most suitable experimental
cell model and exclude cross reactivity with other potential
proteins, we initially screened several cell lines for the
expression of Pax8 using Q-RT-PCR. The Pax8 transcript
was not detected in the human epithelial carcinoma Hela
cell line, the human breast cancer MCF7 cell line or in the
rat insulinoma INS-1E cell line (Fig. 4A). However,
immunofluorescence and Western blot analysis using the
polyclonal Pax8 antibody revealed strong positive staining
Fig. 1 Pax8 transcript levels are low to undetectable in adult human
and mouse islets as compared to Pax6 and Pax4. Quantitative RT-
PCR using RNA purified from freshly isolated mouse and human
islets were performed on Pax8, Pax6, Pax4 and the housekeeping gene
cyclophilin. The Pax4 and Pax8 relative mRNA abundance levels
were established using the 2DDCt method and compared to the
expression levels of Pax6 (arbitrarily indicated as 100). Results
represent the average of at least five experiments performed in
duplicate ± SE (ND non detected)
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in both HeLa and INS-1E, further indicating a possible
non-specificity of the polyclonal antibody (Fig. 4B, C). In
contrast, MCF7 cells were negative for Pax8 staining
(Fig. 4B, C) and we therefore selected this cell line to
further study the specificity of the polyclonal Pax8 anti-
body. Protein extracts derived from MCF7 cells transfected
with human Pax4, Pax6 or Pax8 expression vectors were
blotted with an anti-myc (Pax4) and an anti-Pax6 serum as
well as with the polyclonal Pax8 antibodies. The anti-myc
and anti-Pax6 sera specifically detected Pax4 and Pax6,
respectively. However, although the polyclonal Pax8 anti-
body revealed a strong signal in Pax8-tranfected cells, it
also recognized, albeit with lower intensity, a band of
similar molecular weight in Pax6-transfected MCF7 cells
(Fig. 5A). In contrast, the Pax8 monoclonal antibody
exclusively recognized a band in MCF7 cells transfected
with Pax8 (Fig. 5A). Immunofluorescence analysis per-
formed on Pax-transfected MCF7 cells confirmed that the
polyclonal Pax8 antibody recognized both Pax6 and Pax8
while the monoclonal antibody was specific to Pax8
(Fig. 5B).
The polyclonal Pax8 antibody detects Pax6 in islets
as well as in the developing pancreas
Our findings indicating cross-reactivity of Pax8 polyclonal
antibody with Pax6 raise the possibility that the signal
detected in islet is not Pax8 but Pax6. To verify this pos-
sibility, co-immunofluorescence studies were performed on
both human and mouse disaggregated islets using the
Fig. 2 A polyclonal Pax8
antibody reveals expression of
the transcription factor in
kidney, pancreas and liver
during development.
A Immunohistochemistry
staining using a polyclonal Pax8
antibody shows strong nuclear
staining in kidney and pancreas
and in scattered cells in liver
during embryonic development
(a–f) and in new born pups
(g–i) (scale bar 50 lm).
B Immunofluorescence images
of pancreatic tissue from
neonatal animal incubated with
polyclonal Pax8 (green)
exhibiting strong Pax8 nuclear
staining in the islets while the
surrounding exocrine tissue is
negative. b and c are the
enlarged detail of the islet
indicated in a, showing in c the
co-staining with DAPI (blue) to
reveal the totality of islet cells
Histochem Cell Biol (2011) 136:595–607 599
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Fig. 3 A polyclonal but not a
monoclonal antibody against
Pax8 immunostains adult mouse
or human islets.
A Immunofluorescence analysis
of disaggregated mouse (left
panels) and human (right
panels) islet cells (9400) using
a polyclonal Pax8 antibody
(green) shows, in the majority
of islet cells, a strong nuclear
Pax8 staining. B No
immunostaining was detected
either in mouse (left panels) or
human (right panels) islets
when a monoclonal Pax8
antibody (green) was used
(9400). For the visualization of
all cells, counterstaining with
DAPI (blue) was performed
600 Histochem Cell Biol (2011) 136:595–607
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polyclonal Pax8 antibody together with the anti-Pax6 sera.
Consistent with our hypothesis, all Pax8-positive cells were
also Pax6-positive and single staining for either Pax8 or
Pax6 was never observed in either human or mouse islets
(Fig. 6). These results suggest that Pax8, as initially
reported (Plachov et al. 1990), is most likely not expressed
in the mature pancreas. The latter conclusion, prompt us to
re-appraise whether Pax8 was expressed during pancreas
development. Consecutive sections from E17.5 embryos as
well as from newborn pups and adult pancreas were ana-
lyzed by immunohistochemistry using the polyclonal and
monoclonal Pax8 antibodies or the Pax6 monoclonal anti-
body. Strikingly, overlapping expression patterns within
the developing pancreas and islets were again observed
with the polyclonal Pax8 and Pax6 antibodies (Fig. 7,
compare images from a, d and g to b, e and h). In contrast,
the Pax8 monoclonal antibody revealed no signal either in
the developing pancreas or in adult islets (Fig. 7c, f, i).
These results clearly demonstrate that the Pax8 polyclonal
antibody cross-reacts with Pax6.
Pax8 is not expressed in pancreatic
neuroendocrine tumors
A crucial question that stems from our study is whether
Pax8 is truly expressed in pancreatic neuroendocrine tumors
as claimed by several independent studies, all using the
same Pax8 polyclonal antibody (Haynes et al. 2011; Long
et al. 2010; Sangoi et al. 2011). To address this important
issue, serial sections of pancreatic neuroendocrine tumors
obtained from 9 independent donors were immunostained
with Pax8 antibodies (polyclonal and monoclonal) as well
as with the anti-Pax6 sera. Consistent with previous reports,
the Pax8 polyclonal antibody revealed positive staining in
some but not all tumors. Indeed, seven out of nine tumors
were positive using this antibody (two representative
tumors are shown in Fig. 8A). However, this staining was
not confirmed using the more specific monoclonal Pax8
antibody (Fig. 8A, compare a and d, to c and f). In parallel,
human kidney and liver samples were used as positive and
negative controls for Pax8 expression. Both Pax8 antibodies
Fig. 4 The Pax8 protein but not
the transcript is detected in
various cell lines. A Q-RT-PCR
analysis shows nearly non-
detectable expression levels of
Pax8 in HeLa, MCF-7 and INS-
1E cell lines. The graphic
represents the relative
abundance of Pax8 mRNA in
the different cell lines as
compared to the expression
levels in kidney (arbitrarily
indicated as 100).
B Immunofluorescence analysis
of the same cell lines shows that
only MCF-7 cell line is negative
for immunostaining when using
the Pax8 polyclonal antibody
(green) (middle panel).
Counterstaining with DAPI
(blue) is shown in the left panels
(9400). A detailed image
corresponding to an
enlargement of the indicated
area is showed in the right
panels. C Western blot analysis
of cell extracts using the
polyclonal Pax8 antibody
revealed the presence of an
immunoreactive band of
approximately 48 kD
(corresponding to the molecular
weight of Pax8) in all cell lines
except MCF-7 cells
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Fig. 5 The polyclonal Pax8
antibody cross-reacts with Pax6.
A Western blot analysis of
extracts from MCF-7 cells
transfected with Pax4, Pax6 or
Pax8 expression vectors using
c-Myc (for the detection of
Pax4), Pax6, polyclonal Pax8
and monoclonal Pax8
antibodies. Pax8 polyclonal
antibody detects not only Pax8
(lane 3) but also Pax6 (lane 2),
indicating a cross-reactivity of
this antibody with Pax6. The
other three antibodies used,
including a new monoclonal
Pax8 antibody, are specific.
a-tubulin staining was used
for loading control.
B Immunofluorescence analysis
of transfected MCF-7 cells from
A, using either the polyclonal
(left panels) or a new
monoclonal (right panels) Pax8
antibodies (green). No
immunostaining was detected in
Pax4-transfected MCF-7 cells
with any of the Pax8 antibodies.
However, polyclonal Pax8
antibody is able to detect
exogenous Pax6, indicating the
existence of cross-reactivity of
polyclonal Pax8 antibody with
Pax6 protein. Counterstaining
with DAPI (blue) is shown to
visualize also the non-
transfected cells
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exhibited strong nuclear staining in kidney sections while
no signal was detected in liver sections (Fig. 8B, C).
Interestingly, 3 out of 7 samples displayed strong positive
signal for Pax8 polyclonal antibody as well as for Pax6
antibody suggesting that the signal given by the Pax8
polyclonal antibody is due, at least in part, to the recogni-
tion of the endogenous Pax6 protein (Fig. 8A, upper pan-
els). However, in the four remaining tumors that reacted
with the Pax8 polyclonal antibody, no staining was detected
for Pax6 (Fig. 8A, compare d and e).
Fig. 6 The Pax8 polyclonal
antibody immunostains Pax6 in
both human and mouse adult
islets. Immunofluorescence
analysis of disaggregated mouse
(left panels) and human (right
panels) pancreatic islet cells co-
immunostained with polyclonal
Pax8 (green) and Pax6 (red)
antibodies, shows an overlap in
the staining both in human and
in mouse islets (9400). The
enlargement of the indicated
area (lower panels) shows this
overlap. Counterstaining with
DAPI (blue) is also shown
Histochem Cell Biol (2011) 136:595–607 603
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Discussion
The aim of the current study was to establish whether Pax8
was expressed during pancreas development. The rational
was to complement recent clinical studies demonstrating
the presence of this transcription factor in normal human
islets (Ozcan et al. 2011; Sangoi et al. 2011) as well as in
pancreatic neuroendocrine tumors (Haynes et al. 2011;
Long et al. 2010; Sangoi et al. 2011). However, our Q-RT-
PCR data does not substantiate these studies as Pax8
transcript was not detected in mouse islets and was barely
detectable in human islets. Furthermore, our results reveal
that the most commonly used Pax8 polyclonal antibody
cross-reacts with Pax6 in normal islets and pancreatic
neuroendocrine tumors. The lack of Pax8 immunodetection
in the developing pancreas, islets or pancreatic neuroen-
docrine tumors using a more specific Pax8 monoclonal
antibody suggest that this Pax family member may not be
expressed in the pancreas under normal physiological or
pathophysiological conditions. More importantly, our
results highlight the essentiality of validating the specificity
of antibodies before embarking into large immunohisto-
chemical studies such as the ones performed for Pax8
(Haynes et al. 2011; Long et al. 2010; Sangoi et al. 2011).
Our results also cast serious concerns on the reliability of
using Pax8 as a marker to identify pancreatic neuroendo-
crine tumors as proposed by Sangoi et al. (2011).
What could be the cause of such cross-reactivity? A
plausible explanation may be linked to the peptide antigen
used to generate the Pax8 polyclonal antibody. Indeed this
antibody was raised against a 212 amino acids (aa) poly-
peptide encompassing the N-terminal region of Pax8. This
region includes the notoriously conserved 128 aa paired
DNA binding domain found in all members of the pax gene
Fig. 7 Pax8 is not expressed in the developing mouse pancreas or in
mature islets. Immunostaining of pancreatic consecutive sections
using either the polyclonal (left panels) or monoclonal (right panels)
Pax8 antibody, or the Pax6 antibody (middle panels) reveals an
overlapping signal between Pax6 and the polyclonal Pax8 antibodies.
The monoclonal Pax8 antibody does not stain mouse islets at any
studied age. a–c E17.5, d–f Pup and g–i adult mice. Scale bar 50 lm
604 Histochem Cell Biol (2011) 136:595–607
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family (Lang et al. 2007; Robson et al. 2006). Thus,
immunization using this region will likely produce a mul-
titude of antibodies that will recognize several Pax mem-
bers, including Pax6. Further substantiating the promiscuity
of the Pax8 polyclonal antibody, we also found that this
antibody but not the Pax6 or Pax8 monoclonal antibodies
immunostained four tumor samples suggesting cross reac-
tivity with yet another potential Pax member. As Pax8 along
with Pax5 and Pax2 define group II of the Pax family with
over 95% protein homology in the common paired DNA
binding domain, it is tempting to speculate that Pax5 or
Pax2 are potential culprits. Consistent with this premise,
Sangoi and colleagues recently reported Pax8 immunore-
activity in hematopoietic neoplasms, which they attributed
to cross-reactivity with Pax5, a well-defined marker of
B-lineage hematologic malignancies (Sangoi et al. 2010).
Interestingly, we detected Pax8 staining in the developing
mouse liver using the polyclonal antibody (Fig. 2c, f, i).
This organ is the major site of hematopoiesis during murine
embryonic development (Johnson and Moore 1975) and
therefore expresses high levels of Pax5. The latter may
therefore offer an explanation for false Pax8 staining in the
liver. A similar case of promiscuity in Pax family immu-
noreactivity was recently described for a Pax5 monoclonal
antibody that was found to cross-react with its close relative
Pax2 in nonhematopoietic tissues (Morgenstern et al. 2010).
Interestingly, we have previously demonstrated that Pax2 is
expressed in the endocrine pancreas (Ritz-Laser et al. 2000)
raising the possibility that the Pax8 polyclonal antibody
may also recognize this Pax member. Thus, therefore, a
panel of antibodies against different Pax members should be
screened to determine which Pax proteins are aberrantly
expressed in pancreatic neuroendocrine tumors. Moreover,
validation of the specificity with at least two antibodies
raised against different epitopes would be highly recom-
mended prior to launching large-scale clinical studies.
Fig. 8 Pax8 is not expressed
in human pancreatic
neuroendocrine tumors. A Pax8
or Pax6 immunostaining in two
different pancreatic
neuroendocrine tumors using
polyclonal (a, d) or monoclonal
(c, f) Pax8 antibody, or Pax6
antibody (b, e) reveals the lack
of Pax8 staining when Pax8-
specific monoclonal antibody is
used. Of note, the lower panel
tumor is also negative for Pax6.
B Pax8 or Pax6 immunostaining
in human kidney and C liver
using polyclonal (g, j) or
monoclonal (i, l) Pax8 antibody,
or Pax6 antibody (h, k). An
overlap in the immunostaining
signal between the two Pax8
antibodies in kidney tubule
epithelia, indicates the
expression of Pax8 in this tissue.
No nuclear immunostaining for
Pax6 was detected in kidney.
Pax8 or Pax6 antibodies
revealed no signals in the liver
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In contrast to the Pax8 polyclonal antibody, the immu-
nogen that was used to create the monoclonal antibody was
taken from aa 318–426 of the transcription factor. This
region, located at the carboxy-terminal end of the protein,
is highly divergent among Pax members and should
therefore exhibit target-specific recognition. Nonetheless,
despite the lack of Pax8 immunodetection in normal pan-
creatic islets using this monoclonal antibody, Pax8 tran-
scripts were detected, albeit at low levels, in human islets
suggesting a possible involvement of this transcription
factor in islet physiology. Similar to Pax4, Pax8 expression
may be induced in response to physiological situations that
requires b-cell mass expansion (Brun and Gauthier 2008;
Hu He et al. 2011). Consistent with this idea, expression
levels of Pax8 were shown to increase during pregnancy in
mice (Rieck et al. 2009).
In summary, this study highlights pitfalls of using ill-
defined antibodies as markers to either characterize or
classify human tumors. It is of utmost importance to vali-
date the specificity of antibodies generated against proteins,
which have high homology with other members of the
same family. In this regard, caution should be taken on
whether Pax8 is a reliable marker for pancreatic neuroen-
docrine tumors.
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